Clinical Trial Update: Lenvatinib in Patients With Previously Treated Advanced Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of lenvatinib in previously treated advanced biliary tract cancer shows completed status; investigational targeted therapy evaluation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma

Drugs mentioned

• Lenvatinib (lenvatinib)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Cholangiocarcinoma, Biliary Tract Cancer | Phase 2 | Status: COMPLETED